Well, welcome to the 45th Annual TD Cowen Healthcare Conference. I'm Dan Brennan, follow Tools and Diagnostics. Really pleased to be joined on stage here with Marc Casper, Chairman and President of ...
Q4 2024 Earnings Call Transcript February 28, 2025 Operator: Good afternoon. My name is Ellie, and I will be your conference call operator today. I would like to welcome everyone to Solventum’s Fourth ...
Solventum purification and filtration portfolio expected to be highly complementary with Thermo Fisher’s bioproduction ...
The addition of Solventum’s business provides a strategic fit with Thermo Fisher and will create value for customers, ...
Solventum stock is down, even though fourth-quarter results that came in ahead of the consensus forecast on Wall Street.
Rare Disease Day, an annual gathering hosted by the FDA and National Institutes of Health, was postponed. Medicare spending on 10 diabetes drugs, including popular GLP-1s, more than quadrupled over a ...
Solventum surpassed fourth-quarter revenue and earnings expectations while facing challenges in segments and regulatory ...
Amy Wakeham; SVP of IR; Solventum Corp. Bryan Hanson; CEO & Director; Solventum Corp. Wayde McMillan; CFO; Solventum Corp. Jason Bednar; Analyst; Piper Sandler & Co.
Minnesota-based Solventum is one of the largest providers of sterilization devices, wound dressings, medical tape and other hospital consumables used by healthcare facilities. More than half of its ...
The acquisition of Solventum’s Purification & Filtration business will allow Thermo Fisher Scientific to enhance its ...
Thermo Fisher Scientific Inc. (Waltham, Mass.) announced that the company has entered into a definitive agreement with Solventum to acquire Solventum’s ...
Thermo Fisher Scientific is buying Solventum’s purification & filtration unit for $4.1 billion in cash, strengthening its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results